The Prognostic Impact of HER2 Genetic and Protein Expression in Pancreatic Carcinoma—HER2 Protein and Gene in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is a lethal and clinically heterogeneous disease with a limited benefit from human epidermal growth factor receptor 2 (HER2)-targeted therapy. Recently, some studies have addressed the antitumoral effect of novel anti-HER2 drugs in HER2 low-expressing tumors....

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Song-Hee, Ryu, Ki Hyun, Kwon, Ah-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065582/
https://www.ncbi.nlm.nih.gov/pubmed/33916543
http://dx.doi.org/10.3390/diagnostics11040653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065582/
https://www.ncbi.nlm.nih.gov/pubmed/33916543
http://dx.doi.org/10.3390/diagnostics11040653

Ejemplares similares